Classification of Uterine Adenomyosis

In: Current Obstetrics and Gynecology Reports · 2022 · vol. 11(3) , pp. 186–197 · doi:10.1007/s13669-022-00337-4 · W4225156869
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06+body, 2026-06-12

This review assesses existing classifications of uterine adenomyosis, detailing histopathologic, sonographic, MRI, and clinical criteria for diagnosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This paper is a literature review that examines proposed classification schemes for uterine adenomyosis and evaluates the clinical significance attributed to each approach. It describes major histopathologic classifications (using criteria such as distance from the endometrium, depth of penetration, lesion pattern, and configuration), sonographic classifications (based on multiple uterine structural and lesion characteristics), and MRI classifications (inner/outer uterine layer involvement and lesion solidarity), alongside a treatment-oriented clinical classification. The review’s key finding is that multiple classification systems exist, largely grounded in imaging or histology, and the emerging challenge is integrating pathogenesis, clinical phenotype, imaging features, and histology into a unified framework. It does not present new primary data, and its conclusions depend on the heterogeneity and completeness of the reviewed literature. This paper is centrally about endometriosis and/or adenomyosis — it focuses on uterine adenomyosis classification and specifically contextualizes it within the broader field that also considers related endometrial disorders.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 14,459 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Purpose of Review The purpose of the present study is to review the existing literature regarding the classifications of uterine adenomyosis and to assess the clinical significance of each classification. Recent Findings Adenomyosis is a benign gynecological disease characterized by the presence of ectopic endometrial tissue (glands and stroma) within the myometrium surrounded by hyperplastic and hypertrophic smooth musculature within the uterus. There are several classifications of uterine adenomyosis. The disease is mainly classified in focal adenomyosis, diffuse adenomyosis, and adenomyomas. The histopathologic classification recognizes 4 criteria: the distance of the foci from the endometrium, the depth of the penetration, the pattern of the disease, and the configuration of the lesion. The sonographic classification includes as criteria the abnormalities in (a) the uterine serosa, (b) the definition of the lesion, (c) the symmetry of the uterine walls, (d) the shape, (e) the contour, (f) the shadowing of the lesion, (g) the echogenicity, (h) the vascularity of adenomyosis, and the (i) regularity of the endometrial rim. The MRI classification uses as criteria (a) the presence of disease in the inner uterine layer, (b) the presence of disease in the outer uterine layer, and (c) the solidarity of the lesions. Finally, the clinical, treatment-based classification uses as criteria the extent of the presence of the disease throughout the myometrium, the configuration of the lesion (focal or diffuse), and the consistency of the lesion (cystic/solid, and gland- or muscle-predominant). Summary There are numerous proposed classifications of uterine adenomyosis, mainly based on histopathological and imaging findings. The current emerging challenge is the integration of the pathogenesis, the clinical phenotype, the imaging features, and the histology of the disease, in a common classification that will allow an accurate treatment decision and further satisfactory prognosis of the adenomyotic lesion in all the affected patients. Access this article We’re sorry, something doesn't seem to be working properly. Please try refreshing the page. If that doesn't work, please contact support so we can address the problem. Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance Guerriero S, Dueholm M, Leone F.P.G, Valentin L, Rasmussen C, Votino A, Van Schoubroeck D, Landolfo C, Install AJ. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet. Gynecol. 2015;46:284–98. Prašnikar E, Kunej T, Repnik K, Potocnik U, Knez J, Kovacic B. Determining the molecular background of endometrial receptivity in adenomyosis. Biomolecules. 2020;10:1311. von Rokitansky C. “Uber Uterusdru” sen-Neubildung. Z Gesellschaft Aerzte (Wien). 1860;16:577–81. Sampson JA. Perforating hemorrhagic (chocolate) cysts of the ovary. Their importance and especially their relation to pelvic adenomas of endometrial type. Adenomyoma of the uterus, rectovaginal septum, sigmoid, etc. Arch Surg. 1921;3:245–323. Parrott E, Butterworth M. Green a WIN, Greaves P. Adenomyosis–a result of disordered stromal differentiation. Am J Pathol. 2001;159:623–630. Leyendecker G, Bilgicyildirim A, Inacker M, Stalf T, Huppert P, Mall G, Böttcher B, Wildt L. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015;291: 917–932. Gargett C, Schwab K, Deane J. Endometrial stem/progenitor cells: the first 10 years. Hum Reprod Update. 2016;22:137–63. Chapron C, Tosti, Marcellin L, Bourdon M, Lafay-Pillet M, Millischer A, Streuli I, Borghese B, Petraglia F, Santulli P. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod. 2017;32:1393–1401. Marcellin L, Santulli P, Bortolato S, Morin C, Millischer A, Borghese B, Chapron C. Anterior focal adenomyosis and bladder deep infiltrating endometriosis: is there a link? Minim Invasive Gynecol. 2018;25:896–901. Upson K, Missmer S. Epidemiology of adenomyosis. Semin Reprod Med. 2020;38:89–107. Weiss G, Maseelall P, Schott LL, Brockwell SE, Schocken M, Johnston JM. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women’s Health Across the Nation (SWAN). Fertil Steril. 2009;91:201–6. Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20:547–55. Bourdon M, Santulli P, Marcellin L, Maignien C, Maitrot-Mantelet L, Bordonne C, Plu Bureau G, Chapron C. Adenomyosis: an update regarding its diagnosis and clinical features. Gynecol Obstet Hum Reprod. 2021;50:102228. Naftalin J, Hoo W, Pateman K, Mavrelos D, Foo X, Jurkovic D. Is adenomyosis associated with menorrhagia? Hum Reprod. 2014;29:473–9. Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol. 2000;95:688–91. Condous G, Van B, Van S, Lam A. What is the value of preoperative bimanual pelvic examination in women undergoing laparoscopic total hysterectomy? J Minim Invasive Gynecol. 2007;14:334–8. Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis of adenomyosis: a structured review and meta-analysis of diagnostic accuracy in imaging. J Minim Invasive Gynecol. 2020;27:408–18. Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;13:8. Vercellini P, Parazzini F, Oldani S, Panazza S, Bramante T, Crosignani PG. Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics. Hum Reprod. 1995;10:1160–2. Novak ER, Woodruff JD. Novak's Gynecologic and obstetric pathology: with clinical and endocrine relations. Saunders Philadelphia. 1979. Hendrickson MR, Kempson RL. The differential diagnosis of endometrial adenocarcinoma. Some viewpoints concerning a common diagnostic problem. Pathology. 1980;12:35–61. Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus–revisited. Am J Obstet Gynecol. 1972;112:583–93. Siegler AM, Camilien L. Adenomyosis. J Reprod Med. 1994;39:841–53. Vercellini P, Vigan P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20:465–77. Levy G, Dehaene A, Laurent N, Lernout M, Collinet P, Lucot JP, Lions C, Poncelet E. An update on adenomyosis. Diag Interv Imaging. 2013;94:3–25. Naftalin J, Hoo W, Pateman K, Mavrelos D, Jurkovic D, Holland TK. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27:3432–9. Munro M, Critchley H, Broder M, Fraser I. FIGO working group on menstrual disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3–13. • Van den Bosch T, de Bruijn A, de Leeuw R, Dueholm M, Exacoustos C, Valentin L, Bourne T, Timmerman D, Huirne J. Sonographic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019;53:576–582. This article classifies adenomyosis by ultrasound findings. It represents a holistic sonographic diagnostic approach not only for adenomyosis but for any uterine disease as well. Exacoustos C, Manganaro L, Zupi E. Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clinic Obstet Gynaecol. 2014;28:655–81. • Exacoustos C, Morosetti G, Conway F, Camilli S, Martire F, Lazzeri L, Piccione E, Zupi E. New sonographic classification of adenomyosis: do type and degree of adenomyosis correlate to severity of symptoms? J Minim Invasive Gynecol. 2020;27:1308–1315.This article classifies adenomyosis by ultrasound findings. The authors introduce a classification and scoring system for uterine adenomyosis in an attempt to correlate symptoms to sonographic findings. Vandermeulen L, Cornelis A, Kjaergaard Rasmussen C, Timmerman D, Van den Bosch T. Guiding histological assessment of uterine lesions using 3D in vitro ultrasonography and stereotaxis. Facts Views Vis Obgyn. 2017;9:77–84. Luciano DE, Exacoustos C, Albrecht L, LaMonica R, Proffer A, Zupi E, Luciano AA. Three-dimensional ultrasound in diagnosis of adenomyosis: histologic correlation with ultrasound targeted biopsies of the uterus. J Minim Invasive Gynecol. 2013;20:803–10. Gordts S, Brosens J, Fusi L, Benagiano G, Brosens I. Uterine adenomyosis: a need for uniform terminology and consensus classification. RBM Online. 2008;17:244–8. • Kishi Y, Suginami H, Kuramori R, Yabuta M, Suginami R, Taniguchi F. Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification. Am J Obstet Gynecol. 2012;207:114.e1–114.e7. This article classifies adenomyosis by MRI findings. It represents one of the most important radiologic classifications of the disease. Dashottar S, Singh A, Debnath J, Muralidharan C, Singh R, Kumar S. Comparative analysis of changes in MR imaging of pre and post intrauterine progesterone implants in adenomyosis cases. Med J Armed Forces India. 2015;71:145–51. Jung DC, Kim MD, Oh YT, Won JY, Lee DY. Prediction of early response to uterine arterial embolisation of adenomyosis: value of T2 signal intensity ratio of adenomyosis. Eur Radiol. 2012;22:2044–9. • Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109:389–397. This article classifies adenomyosis by ultrasound and MRI findings. It represents the most recent radiologic classification of the disease. McCausland AM, McCausland VM. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am J Obstet Gynecol. 1996;174(1786–93):93–4. Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2010;89:1374–84. • Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101:472–487. This article classifies adenomyosis by surgical findings. It represents a clinical approach that attempts to relate intra-operative findings with the prognosis of the disease. Mikos T, Lioupis M, Anthoulakis C, Grimbizis GF. The outcome of fertility-sparing and nonfertility-sparing surgery for the treatment of adenomyosis. A systematic review and meta-analysis. J Minim Invasive Gynecol. 2020;27:309–331. McCausland AM. Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical application. Am J Obstet Gynecol. 1992;166(1619–26):26–8. Pistofidis G, Makrakis E, Koukoura O, Bardis N, Balinakos P, Anaf V. Distinct types of uterine adenomyosis based on laparoscopic and histopathologic criteria. Clin Exp Obstet Gynecol. 2014;41:113–8. Panganamamula UR, Harmanli OH, Isik-Akbay EF, Grotegut CA, Dandolu V, Gaughan JP. Is prior uterine surgery a risk factor for adenomyosis? Obstet Gynecol. 2004;104:1034–8. Vavilis D, Agorastos T, Tzafetas J, Loufopoulos A, Vakiani M, Constantinidis T, Patsiaoura K, Bontis J. Adenomyosis at hysterectomy: prevalence and relationship to operative findings and reproductive and menstrual factors. Clin Exp Obstet Gynecol. 1997;24:36–8. Pinzauti S, Lazzeri L, Tosti C, Centini G, Orlandini C, Luisi S, et al. Transvaginal sonographic features of diffuse adenomyosis in 18–30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015;46:730–6. Sammour A, Pirwany I, Usubutun A, Arseneau J, Tulandi T. Correlations between extent and spread of adenomyosis and clinical symptoms. Gynecol Obstet Invest. 2002;54:213–6. Weiss G, Maseelall P, Schott LL, Brockwell SE, Schocken M, Johnston JM. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women’s Health Across the Nation (SWAN). Fertil Steril. 2009;91:201–206. Bruun MR, Arendt LH, Forman A, Ramlau-Hansen CH. Endometriosis and adenomyosis are associated with increased risk of preterm delivery and a small-for-gestational-age child: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018;97:1073–90. Razavi M, Maleki-Hajiagha A, Sepidarkish M, Rouholamin S, Almasi-Hashiani A, Rezaeinejad M. Systematic review and meta-analysis of adverse pregnancy outcomes after uterine adenomyosis. Int J Gynaecol Obstet. 2019;145:149–57. Juang C-M, Chou P, Yen M-S, Twu N-F, Horng H-C, Hsu W-L. Adenomyosis and risk of preterm delivery. BJOG. 2007;114:165–9. Scala C, Leone Roberti Maggiore U, Racca A, Barra F, Vellone VG, Venturini PL, Ferrero S. Influence of adenomyosis on pregnancy and perinatal outcomes in women with endometriosis. Ultrasound Obstet Gynecol. 2018;52:666–671. Kissler S, Zangos S, Vogl TJ, Hamscho N, Gruenwald F, Kohl J, Kaufmann M, Siebzehnruebl E. Impaired utero-tubal sperm transport in adenomyosis and endometriosis—a cause for infertility. Int Congr Ser. 2004;1271:229–31. Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod Biomed Online. 2012;24:35–46. Zouzoulas OD, Tsolakidis D, Efstratiou I, Pervana S, Pazarli E, Grimbizis G. Correlation between Adenomyosis and Endometrial cancer: 6-year experience of a single center. Facts Views Vis Obgyn. 2018;10:147–52. Author information Authors and Affiliations Corresponding author Ethics declarations Conflict of Interest The authors declare that they have no conflict of interest. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This article is part of the Topical Collection on Uterine Fibroids and Endometrial Lesions Rights and permissions About this article Cite this article Zymperdikas, C., Mikos, T. & Grimbizis, G.F. Classification of Uterine Adenomyosis. Curr Obstet Gynecol Rep 11, 186–197 (2022). https://doi.org/10.1007/s13669-022-00337-4 Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s13669-022-00337-4

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (46)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK